Stocks
Vanda Pharmaceuticals (VNDA) EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| EBITDA, bln rub | ? | 45.0 | 9.06 | -10.9 | -32.5 | -139.3 | -160.6 | |
| Changes by years, y/y, % | +50% | -80% | -221% | +197% | +328% | |||
Vanda Pharmaceuticals. EBITDA US GAAP, bln rub
Vanda Pharmaceuticals. EBITDA US GAAP, changes, %
Vanda Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Vanda Pharmaceuticals (VNDA) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -32.9 | -29.2 | -34.5 | -50.2 | -46.7 | -160.6 | |
| Changes by years, y/y, % | +302% | +224% | +315% | +61% | +50% | |||
| Changes by quarters, q/q, % | +6% | -11% | +18% | +46% | -7% | |||
